MetaVia Unveils Promising ADA 2026 Data for Obesity Pipeline
CAMBRIDGE, Massachusetts, USA – June 8, 2026 MetaVia Inc. has unveiled new late-breaking clinical and preclinical data at the...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
CAMBRIDGE, Massachusetts, USA – June 8, 2026 MetaVia Inc. has unveiled new late-breaking clinical and preclinical data at the...
OXFORD, UK AND CAMBRIDGE, Massachusetts – June 8, 2026 Moderna and the University of Oxford have received authorization from...
NEW BRUNSWICK, New Jersey, USA – June 8, 2026 Johnson & Johnson has announced a definitive agreement to acquire...
MILFORD, Massachusetts, USA – June 3, 2026 Waters Corporation has announced U.S. Food and Drug Administration (FDA) 510(k) clearance...
